Digoxin
Who holds supplier records for Digoxin? 4 organisations hold a current record for Digoxin: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: United States (2) and India (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Digoxin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/digoxin
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in United States
2 of the 3 current records with a recorded country list United States. Organisation country is not necessarily the manufacturing site.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Digoxin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALCHEM INTERNATIONAL LTDUnited StatesCEPActive DMF 27605, 30724 · latest filing Jul 2016
- C-SQUARED PHARMA LTDUnited StatesCEPActive DMF 24418 · latest filing Dec 2010
- IndiaCEP
- ROCHE DIAGNOSTICS GMBHCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Digoxin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| DECCAN NUTRACEUTICALS PRIVATE LIMITED Pune | IN | CEP 2010-298 - Rev 02 Digoxin, Micronised, non-micronised | Apr 2025 | — |
| C-SQUARED PHARMA LIMITED Cork | IE | CEP 2021-171 - Rev 01 Digoxin, Micron 10 | Aug 2024 | — |
| ALCHEM INTERNATIONAL PRIVATE LIMITED Faridabad | IN | R1-CEP 2016-234 - Rev 00 Digoxin, Micronised | Oct 2022 | — |
| Roche Diagnostics GmbH Mannheim | DE | R1-CEP 1996-048 - Rev 02 Digoxin | Nov 2006 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Digoxin are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- C-SQUARED PHARMA SARLInactive DMF 33035 · filed Oct 2019
- India · Inactive DMF 24135 · filed Aug 2010
- PROCTER AND GAMBLE PHARMACEUTICALS INC SUB PROCTER AND GAMBLE COInactive DMF 10067 · filed Jan 1993
- Germany · Inactive DMF 6926 · filed Apr 1987
Overview
Digoxin is a cardiac glycoside derived from the foxglove plant, Digitalis lanata. It is used to treat various heart conditions, particularly atrial fibrillation and heart failure.
Chemical identity
- IUPAC name
- 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
- Canonical SMILES
- C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
- InChIKey
- LTMHDMANZUZIPE-PUGKRICDSA-N
- Synonyms
- Lanoxin API, digoxinum, dynamos, fargoxin, lanocardin, lanoxin, mapluxin, natigoxin, nsc-95100, rougoxin, stillacor-, toloxin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cardiac Glycoside
- Chemical structure
- Cardiac Glycosides
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Digoxin?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Digoxin: ALCHEM INTERNATIONAL LTD (United States), C-SQUARED PHARMA LTD (United States), DECCAN NUTRACEUTICALS PVT LTD (India) and ROCHE DIAGNOSTICS GMBH. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Digoxin Drug Master Files are active?
ALCHEM INTERNATIONAL LTD (DMF 27605, 30724) and C-SQUARED PHARMA LTD (DMF 24418). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Digoxin records mean?
4 organisations have only inactive Type II DMFs for Digoxin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Digoxin have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Digoxin on the EDQM register, including DECCAN NUTRACEUTICALS PRIVATE LIMITED Pune (IN), C-SQUARED PHARMA LIMITED Cork (IE), ALCHEM INTERNATIONAL PRIVATE LIMITED Faridabad (IN) and Roche Diagnostics GmbH Mannheim (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Digoxin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Digoxin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.